Fakhar Z, Khan S, AlOmar SY, Alkhuriji A, Ahmad A. ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19. Sci Rep. 2021;11(1):234.
ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
By Content Specialist|2022-06-30T08:05:32+02:00June 30, 2022|2021: January to March|Comments Off on ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
Corrigendum to “Paclitaxel alleviates the sepsis-induced acute kidney injury via lnc-MALAT1/miR-370-3p/HMGB1 axis” [Life Sci. 2020 Dec 1; 262:118505. doi:10.1016/j.lfs.2020.118505. Epub 2020 Sep 28].